title: The emerging fields of suicide gene therapy and virotherapy.
abstract: Gene therapy is defined as a technology aimed at modifying the genetic component of cells for therapeutic benefit. 'Suicide genes' can be introduced into cancer cells to make them more sensitive to chemotherapeutics or toxins. Chemotherapeutic suicide gene therapy approaches are known as gene-directed enzyme prodrug therapy or gene-prodrug activation therapy. Other approaches include replacement gene therapy, antisense strategies and induction of resistance to normal cells. All gene therapy strategies share a common component, which is the need for a selective delivery vehicle or vector with tumor-targeting capabilities. This need has led to the in-depth investigation of viruses as new vectors for gene therapy.
authors.affiliation: Viral and Genetic Therapy Programme, Imperial College School of Medicine, Hammersmith Hospital, DuCane Road, London, UK W12 0NN.
authors.forename: David
authors.initials: D
authors.lastname: Kirn
authors.forename: Ion
authors.initials: I
authors.lastname: Niculescu-Duvaz
authors.forename: Gunnel
authors.initials: G
authors.lastname: Hallden
authors.forename: Caroline J
authors.initials: CJ
authors.lastname: Springer
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000628:therapy* / Q000821:virology; D011355:Prodrugs / Q000627:therapeutic use*; D012190:Retroviridae / Q000235:genetics; D014616:Vaccinia virus / Q000235:genetics
chemical_list: D011355:Prodrugs